Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Talarico

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|October 20, 2001
Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistanceH H Balfour, C K Edelman, R S Anderson, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV sheddingJacob P Lalezari, Judith A Aberg, Laurene H Wang, et al.
The Journal of Infectious Diseases|April 14, 2000
Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonateR J Oram, D Marcellino, D Strauss, et al.
International Journal of Cardiac Imaging|September 1, 1996
Simultaneous dobutamine stress echocardiography and dobutamine scintigraphy (99mTc-MIBI-SPET) for assessment of coronary artery diseaseV De Bello, C R Bellina, N Molea, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 1, 1996
Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery diseaseV Di Bello, C R Bellina, E Gori, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Acyclovir is phosphorylated by the human cytomegalovirus UL97 proteinC L Talarico, T C Burnette, W H Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2019
A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 InfectionEdwin DeJesus, Sara Harward, Roxanne C Jewell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized TrialKelly E Dooley, Richard Kaplan, Noluthando Mwelase, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responsesRobert J Durso, Sofija Andjelic, Jason P Gardner, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of actionKaren K Biron, Robert J Harvey, Stanley C Chamberlain, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|October 20, 2001
Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistanceH H Balfour, C K Edelman, R S Anderson, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV sheddingJacob P Lalezari, Judith A Aberg, Laurene H Wang, et al.
The Journal of Infectious Diseases|April 14, 2000
Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonateR J Oram, D Marcellino, D Strauss, et al.
International Journal of Cardiac Imaging|September 1, 1996
Simultaneous dobutamine stress echocardiography and dobutamine scintigraphy (99mTc-MIBI-SPET) for assessment of coronary artery diseaseV De Bello, C R Bellina, N Molea, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 1, 1996
Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery diseaseV Di Bello, C R Bellina, E Gori, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Acyclovir is phosphorylated by the human cytomegalovirus UL97 proteinC L Talarico, T C Burnette, W H Miller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2019
A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 InfectionEdwin DeJesus, Sara Harward, Roxanne C Jewell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized TrialKelly E Dooley, Richard Kaplan, Noluthando Mwelase, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responsesRobert J Durso, Sofija Andjelic, Jason P Gardner, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of actionKaren K Biron, Robert J Harvey, Stanley C Chamberlain, et al.
Pageof 8